GlassScriptPhysician profile
Michael J Dragun
NPI 1679574099
$3,002.49
in general payments reported to CMS, 2019-2025
17 companies · $738 in 2025
The $738 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $80.26 · 2021: $268 · 2022: $227 · 2023: $1,279 · 2024: $119 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Travel and Lodging: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.79 |
| Travel and Lodging | $744.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,444.39 | 2019-2025 | Ams 700, General - Therapies, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $548.12 | 2019-2024 | Myrbetriq, Veozah |
| Procept Biorobotics Corporation | $495.73 | 2025 | |
| Sumitomo Pharma America, INC. | $75.90 | 2024-2025 | Gemtesa |
| Axonics, INC. | $66.43 | 2023-2024 | Axonics |
| Janssen Biotech, INC. | $65.76 | 2019-2023 | Erleada |
| Coloplast Corp | $60.73 | 2021 | |
| Dendreon Pharmaceuticals LLC | $45.57 | 2019 | |
| Dornier Medtech America, INC | $39.98 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $36.62 | 2021-2022 | |
| Innovation Technologies INC | $24.81 | 2023 | Irrisept |
| Healthtronics Stone Solutions, LLC | $22.05 | 2019 | |
| Urogen Pharma, INC. | $18.89 | 2024 | |
| Travere Therapeutics, INC. | $15.76 | 2019-2022 | |
| Neotract INC. | $15.21 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $13.70 | 2023 | |
| Abbvie INC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dragun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.